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Abstract
Background: RNA Editing is a type of post-transcriptional modification that takes place in the eukaryotes. It alters
the sequence of primary RNA transcripts by deleting, inserting or modifying residues. Several forms of RNA editing
have been discovered including A-to-I, C-to-U, U-to-C and G-to-A. In recent years, the application of global
approaches to the study of A-to-I editing, including high throughput sequencing, has led to important advances.
However, in spite of enormous efforts, the real biological mechanism underlying this phenomenon remains
unknown.
Description: In this work, we present VIRGO (http://atlas.dmi.unict.it/virgo/), a web-based tool that maps Ato-G
mismatches between genomic and EST sequences as candidate A-to-I editing sites. VIRGO is built on top of a
knowledge-base integrating information of genes from UCSC, EST of NCBI, SNPs, DARNED, and Next Generations
Sequencing data. The tool is equipped with a user-friendly interface allowing users to analyze genomic sequences
in order to identify candidate A-to-I editing sites.
Conclusions: VIRGO is a powerful tool allowing a systematic identification of putative A-to-I editing sites in
genomic sequences. The integration of NGS data allows the computation of p-values and adjusted p-values to
measure the mapped editing sites confidence. The whole knowledge base is available for download and will be
continuously updated as new NGS data becomes available.
Background
RNA Editing is a type of post-transcriptional modification
that takes place in eukaryotes. It alters the sequence of pri-
mary RNA transcripts by deleting, inserting or modifying
residues. Several forms of RNA editing have been discov-
ered including A-to-I, C-to-U, U-to-C and G-to-A. Here
we focus on A-to-I editing (Adenosine-to-Inosine), the
most frequent and common one [1]. Adenosine (A) dea-
mination produces its conversion into inosine (I), which,
in turn, is interpreted by both the translation machinery
and the splicing machinery [2] as guanosine (G). Since
inosine binds cytosine (C), the A-U base pairs in the
secondary structure are changed into I:U mismatches [3].
This biological phenomenon is catalyzed by enzymes
members of the Adenosine Deaminase Acting on RNA
(ADAR) family and occurs only on dsRNA structures
[1,4,5].
The A-to-I RNA editing may be either promiscuous or
specific. The promiscuous RNA editing occurs within
long duplexes [6,7], while specific RNA editing A-to-I
occurs within shorter duplex regions, often formed by an
exon and an intron sequence [8]. Moreover, it has been
reported that A-to-I RNA editing can target both exonic
and intronic regions as well as 5’ and 3’-UTRs regions.
This can have different consequences in the biogenesis of
mRNA [2,9], the translation [1], the mRNA export from
the nucleus to the cytoplasm [10,11], and the degradation
of I-containing mRNA molecules [12]. In the last few
years, it has been reported that RNA editing may occur
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in small noncoding RNA molecules in particular within
precursor-tRNA [13] and pri-miRNAs [14,15]. It has
been estimated that ~ 16% of these sequences undergo
A-to-I editing [14], influencing the pri-miRNA’s matura-
tion process [16] and, consequently, the recognition of
binding sites on target mRNAs [17-19].
It is well known that the activity of RNA editing is
higher in mRNAs of mammalian brain than other tis-
sues [20] and this leads to the assumption that editing
plays a crucial role in the central nervous system [3].
Therefore, malfunctions of ADARs could lead to serious
consequences, in particular it has been observed that an
imbalance of ADAR expression/activity induces a variety
of human diseases [21].
A common approach to identify putative A-to-I editing
sites relies on the alignment of the cloned cDNA gene
sequence to its genomic sequence highlighting A-to-G
mismatches. Recent literature reports different screenings
designed to detect A-to-I RNA editing sites in human,
especially in ALU-type repetitive elements located also in
UTRs regions [6,7,22-25]. Li et al. [26] presented an
unbiased assay to select more than 36, 000 computation-
ally predicted non-repetitive A-to-I sites. The sites were
detected using amplified and sequenced padlock probes.
The authors used cDNA and gDNA from several tissues
and derived from a single individual. These methods led
to the discovery of thousands of ADAR substrates which
may help clarify the function of A-to-I RNA editing on the
regulation of gene expression and quantify the impact of
A-to-I editing on transcriptome and proteome diversity.
Eggington et al. [27] provide a web-based application
which predicts editing sites in dsRNA of any sequence
using Sanger sequencing protocols to perform a more
accurate quantitative analysis. More recently, in contrast
to the previous approaches, new methods, based on Next
Generation Sequencing (NGS) data, have been developed
to identify A-to-I editing sites [28-32]. These new
approaches have allowed the detection of novel editing
sites within coding and non-coding genes [33]. On the
other hand they produced a high number of false editing
sites, since the NGS technology is prone to error [31].
Few systems are available on the web. dbRES [34] was
the first web-oriented database for annotated RNA editing
sites, but the last update goes back to 2007 and contains
only a few dozen of human editing sites. More recently,
Kiran and Baranov created DARNED [35], the largest
database of human RNA editing sites providing a centra-
lized access to published data. RNA editing locations are
mapped on the reference human genome. DARNED is
periodically updated and contains more than 300,000 edit-
ing sites, but no statistical significance is provided. In
2011, Picardi et al. presented Expedit [29]. It is a web
application that maps data and, given individual sequence
reads as input, executes a comparative analysis against
DARNED editing sites. No statistical significance of results
is given.
In this work, we present VIRGO (Visualization of A-to-I
RNA editing sites into GenOmic sequences, http://atlas.
dmi.unict.it/virgo/), a knowledge-base equipped with a
web-interface allowing users to map putative and known
A-to-I editing sites into gene regions (including coding
sequences, introns, and UTRs). We consider as putative
editing sites A-to-G mismatches between genomic and
EST sequences, while known A-to-I editing sites are
obtained from DARNED.
VIRGO borrows from literature the basic computa-
tional techniques that are used to identify A-to-G mis-
matches as putative editing sites. These bioinformatics
methods and resources (i.e. alignment between geno-
mic and EST sequences, clustering, double strand RNA
region identification, Next Generation Sequencing
data) are then integrated into a workflow (see Figure 1)
allowing users to facilitate the analysis of genomic
sequences.
In particular, the VIRGO knowledge-base has been cre-
ated by matching all the human genes regions obtained
from UCSC (hg19) to the EST database using filters and
NGS data. The filters allow the selection of candidate edit-
ing events in clusters [36], lying in repeated and double
strand regions and not classified as SNPs. Moreover,
VIRGO locally maps all the editing events stored in
DARNED. This feature allows the visualization of all
DARNED editing sites through the VIRGO web interface.
Finally, VIRGO uses the DARNED editing sites for which
NGS information is available to compute the expected fre-
quencies of A to G substitution that can happen in a mis-
match aligned column. This knowledge is then used to
compute p-values for all VIRGO editing events for which
NGS information is available.
The VIRGO web interface allows annotation of geno-
mic sequences, provided by users, known editing sites
and those sites passing the filters described above.
Construction and content
VIRGO is a knowledge base that integrates information
retrieved from specialized biological databases. The core
of the system has been developed in C++, while the
front-end consists of a web interface developed in PHP.
The data integration process implemented in VIRGO
consists of a sequence of steps carried out to identify
putative A-to-I editing sites (see Figure 1). The database
construction, which has been done offline, includes six
steps. All filters are mandatory, therefore, a site that does
not pass one of such steps is discarded. The last step is
applied only when mismatches align with the NGS reads.
The steps are described below.
Step 1. We downloaded the whole set of human genes
from UCSC (http://genome.ucsc.edu/buildGRCCh37/
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hg19). Then, using BLASTN, we aligned all the genes
with NCBI EST database. Although this step is very
time consuming, it allows us to identify all the potential
A-to-I editing sites. VIRGO creates an initial database
by selecting the A-G mismatches between the genes and
the EST sequences.
Step 2. According to [36], editing events usually hap-
pen in cluster. After binding the mRNA, ADAR creates
bunches of close editing events. An edited sequence
typically shows editing in many close-by sites. Therefore,
it is very unlikely to observe isolated editing events
inside a sequence. The clustering filter implements the
methodology presented in [36] by selecting A-G mis-
matches that are followed by at least three mismatches
of the same kind, without gaps or other types of mis-
matches (see Figure 2 for an example).
Step 3. VIRGO partitions the selected mismatches in
three categories. To achieve that, we label the genes as
falling in ALU regions (T0), in repeat regions (T1), and
in non repeat region (T2).
Step 4. VIRGO verifies whether mismatches (from all
the classes created above) occur into double-stranded
regions. For this purpose we applied a technique already
used in [6,36] for the prediction of the double strand por-
tion of a RNA secondary structure. It creates a short
reverse complementary sequence centered on each mis-
match by retrieving upstream and downstream flanking
nucleotides. Then it searches for the constructed reverse
complementary sequence into the gene where the mis-
match has been found. In particular, when a mismatch
occurs into an ALU repetitive region the length of the
short complementary sequence is equal to the length of
the ALU region. Otherwise, the length of the short
sequence is equal to 251 nucleotides including the
mismatch.
Next, VIRGO aligns the created sequence with a region
with no more than 4001 nucleotides centered on the A-G
mismatch. Since the length of the reverse complement in
ALU and repeat regions is not constant we set the mini-
mum length for the alignments to be 85% of the length of
the sequence (i.e. the alignment consists of at least 214
nucleotides over 251). Consequently, in the alignment we
look for an identity of at least 85%. VIRGO annotates that
mismatch as occurring into a double-strand region [6,36]
(see Figure 3 for an example).
Step 5. VIRGO, uses the database All SNPs(135) con-
tained in UCSC, to filter the mismatches that are
already classified as SNPs.
Step 6. VIRGO performs an alignment of the genes
with a subset of NGS data taken from the following
experiments: SRP002274 - GSE19166 (http://www.ncbi.
nlm.nih.gov/Traces/sra/sra.cgi?study=SRP002274) and
SRP007465 (http://www.ncbi.nlm.nih.gov/Traces/sra/
sra.cgi?study=SRP007465).
The subset of short reads is constructed as follows.
Alignment of human genome with short reads is per-
formed by BOWTIE [37]. In order to reduce noise, only
the best alignments with at most two mismatches by
Figure 1 Sequence of steps to identify putative A-to-I editing
sites. The pipeline that VIRGO uses to built the knowledge base.
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using -a and -v parameters are accepted. By specifying -a,
VIRGO instructs BOWTIE to report all valid alignments,
subjected to the alignment policy -v 2 (at most two mis-
matches are allowed).
The selected short reads are mapped on each VIRGO
mismatch, selecting those mismatches occurring into at
least five short reads. This alignment allows to compute,
for some of the editing events, p-value and adjusted
p-value yielding the confidence that the candidate mis-
match is not a false positive.
Our approach to compute the p-values of candidate sites
uses the expected A/G frequencies in the aligned columns
versus the observed one in connection to a Fisher exact
test. To compute these expected frequencies we used all
the DARNED editing sites having an alignment with some
NGS reads (we set to five the minimum number of reads
aligning the gene region). In order to calculate the p-value,
for each selected mismatch the nucleotides present in the
corresponding alignment columns are considered. Only
columns containing Adenosine and Guanosine are taken
into account. For each editing site reported in DARNED
and aligned with the NGS reads we computed the fre-
quencies of A and G nucleotides in the column corre-
sponding to the mismatch. Then, we take the average
frequencies of A and G for all aligned DARNED editing
sites. We consider as observed frequencies those coming
from a mismatch visualized by VIRGO which has an align-
ment with NGS reads. These frequencies (expected/
observed) are then used through the Fisher’s Exact Test to
compute the putative site p-value (see Figure 4 for an
example).
The significance of those mismatches for which it was
not possible to compute the p-values was annotated as
unknown.
Finally, p-values have been adjusted applying FDR cor-
rection for testing multiple hypotheses, with a = 0.01.
Each p-value is periodically updated by using new NGS
experiments.
Utility and discussion
VIRGO aims to be an efficient and user-friendly system,
providing an interface by which users can analyze and
Figure 2 Clustering filter. The A-G mismatch in blue color is followed by three mismatches of the same type (in red color). Furthermore, no
gaps are present. The three mismatches following the initial candidate editing site are included as putative editing events and are highlighted
in the alignment with ESTs.
Figure 3 Fourth Step. VIRGO verifies whether mismatches occur into double-stranded regions by creating a short reverse complementary
sequences centered on the mismatch. VIRGO aligns the created sequence with a region of maximum 4001 nucleotides centered on the A-G
mismatch. If the percentage of the alignment is greater than or equal to 85%, VIRGO annotates that mismatch as occurring into a double-strand
region.
Distefano et al. BMC Bioinformatics 2013, 14(Suppl 7):S5
http://www.biomedcentral.com/1471-2105/14/S7/S5
Page 4 of 7
visualize their data, and export results into xml and txt
files.
The central purpose of VIRGO is to provide users
with a periodically updated system which stores high-
quality candidate editing sites. This will allow users to
quickly and easily identify whether their genomic
sequences are subject to A-to-I RNA Editing.
The user can submit an input file containing headers of
sequences in a specific BED-like format (see the website
for input examples). Note that improperly formatted input
sequences will not be analyzed. Once the analysis starts, a
temporary page containing a link to the results page is
generated (see Figure 5). The left part of the results page
shows the sequences that have been analyzed. Each
sequence is partitioned into segments of 80 nucleotides
each. All known mismatches (obtained from DARNED)
are identified by blue marks placed on top of them (see
number 1 in Figure 5). In Figure 6 we show, through a
Venn diagram [38], the number of common sites shared
by VIRGO and DARNED. Notice that, only a small por-
tion of VIRGO editing sites overlaps with those present in
DARNED. There are several arguments to explain this.
First of all, RNA-editing is a dynamic event; this means
that the presence of edited adenosines can have, in princi-
ple, a strong variability. For example, a sequenced tran-
script can have an edited adenosine in a specific position
in an experiment which is absent in the same sequenced
transcript in a second experiment. This conjecture is sup-
ported by the fact that most of the data included in
DARNED come from experiments in which authors
synthesized their own ETSs or NGS transcripts. Within
this context, tools as Virgo are useful to help investigation.
A second reason relies on the fact that the second phase
(clustering filter) of VIRGO hides those candidate editing
events that do not happen in clusters. However, since edit-
ing is rarely an-all-or-nothing mechanism, we are confi-
dent that our dataset, being based on the actual EST
sequence reads, gives an accurate measure for the editing
events occurring in vivo.
The sites identified by VIRGO are marked with different
colors (yellow, orange, red, purple) according to the Num-
ber of Aligned ESTs (NAEs. The colors with respect to the
NAEs are: (yellow)1 ≤ NAE ≤ 5, (orange)5 <NAE ≤ 10,
(red) 10 <NAE ≤ 20, (fuxia) NAE ≥ 20). They are placed at
the bottom of sequences (see number 2 in Figure 5). By
clicking on a blue marker, VIRGO shows the following
information: chromosome, genomic position, strand,
p-value, tissue/organ (if known), if it is a SNP and the
PUBMED resources.
Markers relative to newly predicted sites will give infor-
mation on chromosome, genomic position, strand, and
p-value. When a mismatch occurs inside a repeat region,
Figure 4 Toy example for the p-value computation.
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its start/end genomic position, strand, chromosome, name,
class and family will be given. The list of EST sequences in
which the mismatch occurs is given. For each EST
sequence, VIRGO shows the EST name, tissue and organ
(if known), the alignment between the input gene and EST
sequence, and the NCBI information. The list of isoforms
where the mismatch occurs is also provided. For each iso-
form, information such as the refSeq ID, chromosome,
strand, starting and ending genomic position, among
others, are provided (see number 3, 4 and 5 in Figure 5).
Finally, the results of the analysis will be stored into the
server for 5 days and then removed.
Conclusions
RNA Editing is an important post-transcriptional mechan-
ism which contributes to the diversity of transcriptome. It
alters the sequence of primary RNA transcripts by delet-
ing, inserting or modifying residues. Here we focus on
A-to-I editing (Adenosine-to-Inosine), the most frequent
and common one. The main goal of VIRGO is to provide
a simple system aiming to identify known and putative
A-to-I RNA editing sites into user provided genomic
sequences. By exploiting NGS data, VIRGO is able to
compute, for each predicted editing site, a p-value to mea-
sure the confidence of the prediction. Predictions can be
downloaded in xml and txt format. Finally, the whole
VIRGO database can be downloaded and used in third
party applications.
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